{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:33:20Z","timestamp":1787020400566,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:00:00Z","timestamp":1594944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:00:00Z","timestamp":1594944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01-HL108927"],"award-info":[{"award-number":["R01-HL108927"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30-DK065988"],"award-info":[{"award-number":["P30-DK065988"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000292","name":"Cystic Fibrosis Trust","doi-asserted-by":"publisher","award":["SRC003"],"award-info":[{"award-number":["SRC003"]}],"id":[{"id":"10.13039\/501100000292","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["R026-CR11"],"award-info":[{"award-number":["R026-CR11"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["TARRAN17G0"],"award-info":[{"award-number":["TARRAN17G0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cystic fibrosis (CF) patients are extremely vulnerable to\n                    <jats:italic>Burkholderia cepacia<\/jats:italic>\n                    complex (Bcc) infections. However, the underlying etiology is poorly understood. We tested the hypothesis that short palate lung and nasal epithelial clone 1 (SPLUNC1)\u2013epithelial sodium channel (ENaC) interactions at the plasma membrane are required to reduce Bcc burden in normal airways. To determine if SPLUNC1 was needed to reduce Bcc burden in the airways, SPLUNC1 knockout mice and their wild-type littermates were infected with\n                    <jats:italic>B. cenocepacia<\/jats:italic>\n                    strain J2315. SPLUNC1 knockout mice had increased bacterial burden in the lungs compared to wild-type littermate mice. SPLUNC1-knockdown primary human bronchial epithelia (HBECs) were incubated with J2315, which resulted in increased bacterial burden compared to non-transduced HBECs. We next determined the interaction of the SPLUNC1-ENaC complex during J2315 infection. SPLUNC1 remained at the apical plasma membrane of normal HBECs but less was present at the apical plasma membrane of CF HBECs. Additionally, SPLUNC1-\u03b2ENaC complexes reduced intracellular J2315 burden. Our data indicate that (i) secreted SPLUNC1 is required to reduce J2315 burden in the airways and (ii) its interaction with ENaC prevents cellular invasion of J2315.\n                  <\/jats:p>","DOI":"10.1186\/s12931-020-01454-5","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T10:26:01Z","timestamp":1594981561000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The SPLUNC1-\u03b2ENaC complex prevents Burkholderia cenocepacia invasion in normal airway epithelia"],"prefix":"10.1186","volume":"21","author":[{"given":"Saira","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine Seul Ki","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Tarran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,17]]},"reference":[{"key":"1454_CR1","first-page":"CD009529","volume":"1","author":"A Horsley","year":"2016","unstructured":"Horsley A, Jones AM, Lord R. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation. Cochrane Database Syst Rev. 2016;1:CD009529.","journal-title":"Cochrane Database Syst Rev"},{"key":"1454_CR2","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1164\/rccm.201407-1277OC","volume":"190","author":"KA Ramsey","year":"2014","unstructured":"Ramsey KA, Ranganathan S, Park J, Skoric B, Adams AM, Simpson SJ, et al. Early respiratory infection is associated with reduced spirometry in children with cystic fibrosis. Am J Respir Crit Care Med. 2014;190:1111\u20136.","journal-title":"Am J Respir Crit Care Med"},{"key":"1454_CR3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1128\/CMR.15.2.194-222.2002","volume":"15","author":"JB Lyczak","year":"2002","unstructured":"Lyczak JB, Cannon CL, Pier GB. Lung infections associated with cystic fibrosis. Clin Microbiol Rev. 2002;15:194\u2013222.","journal-title":"Clin Microbiol Rev"},{"key":"1454_CR4","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/S0140-6736(16)00576-6","volume":"388","author":"JS Elborn","year":"2016","unstructured":"Elborn JS. Cystic fibrosis. Lancet. 2016;388:2519\u201331.","journal-title":"Lancet"},{"key":"1454_CR5","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1099\/0022-1317-51-7-533","volume":"51","author":"E Mahenthiralingam","year":"2002","unstructured":"Mahenthiralingam E, Baldwin A, Vandamme P. Burkholderia cepacia complex infection in patients with cystic fibrosis. J Med Microbiol. 2002;51:533\u20138.","journal-title":"J Med Microbiol"},{"key":"1454_CR6","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1086\/322684","volume":"33","author":"E Mahenthiralingam","year":"2001","unstructured":"Mahenthiralingam E, Vandamme P, Campbell ME, Henry DA, Gravelle AM, Wong LT, et al. Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans. Clin Infect Dis. 2001;33:1469\u201375.","journal-title":"Clin Infect Dis"},{"key":"1454_CR7","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1099\/ijs.0.65634-0","volume":"58","author":"E Vanlaere","year":"2008","unstructured":"Vanlaere E, Lipuma JJ, Baldwin A, Henry D, De Brandt E, Mahenthiralingam E, et al. Burkholderia latens sp. nov., Burkholderia diffusa sp. nov., Burkholderia arboris sp. nov., Burkholderia seminalis sp. nov. and Burkholderia metallica sp. nov., novel species within the Burkholderia cepacia complex. Int J Syst Evol Microbiol. 2008;58:1580\u201390.","journal-title":"Int J Syst Evol Microbiol"},{"key":"1454_CR8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/mr.60.3.539-574.1996","volume":"60","author":"JR Govan","year":"1996","unstructured":"Govan JR, Deretic V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev. 1996;60:539\u201374.","journal-title":"Microbiol Rev"},{"key":"1454_CR9","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1128\/iai.64.10.4054-4059.1996","volume":"64","author":"JL Burns","year":"1996","unstructured":"Burns JL, Jonas M, Chi EY, Clark DK, Berger A, Griffith A. Invasion of respiratory epithelial cells by Burkholderia (pseudomonas) cepacia. Infect Immun. 1996;64:4054\u20139.","journal-title":"Infect Immun"},{"key":"1454_CR10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1128\/IAI.68.1.24-29.2000","volume":"68","author":"DW Martin","year":"2000","unstructured":"Martin DW, Mohr CD. Invasion and intracellular survival of Burkholderia cepacia. Infect Immun. 2000;68:24\u20139.","journal-title":"Infect Immun"},{"key":"1454_CR11","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.drup.2016.07.003","volume":"28","author":"KA Rhodes","year":"2016","unstructured":"Rhodes KA, Schweizer HP. Antibiotic resistance in Burkholderia species. Drug Resist Updat. 2016;28:82\u201390.","journal-title":"Drug Resist Updat"},{"key":"1454_CR12","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1128\/AAC.42.9.2206","volume":"42","author":"J Turner","year":"1998","unstructured":"Turner J, Cho Y, Dinh NN, Waring AJ, Lehrer RI. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother. 1998;42:2206\u201314.","journal-title":"Antimicrob Agents Chemother"},{"key":"1454_CR13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1164\/ajrccm.163.1.9811076","volume":"163","author":"C Chaparro","year":"2001","unstructured":"Chaparro C, Maurer J, Gutierrez C, Krajden M, Chan C, Winton T, et al. Infection with Burkholderia cepacia in cystic fibrosis: outcome following lung transplantation. Am J Respir Crit Care Med. 2001;163:43\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"1454_CR14","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0167-4781(00)00196-2","volume":"1493","author":"CD Bingle","year":"2000","unstructured":"Bingle CD, Bingle L. Characterisation of the human plunc gene, a gene product with an upper airways and nasopharyngeal restricted expression pattern. Biochim Biophys Acta. 2000;1493:363\u20137.","journal-title":"Biochim Biophys Acta"},{"key":"1454_CR15","doi-asserted-by":"crossref","first-page":"e9098","DOI":"10.1371\/journal.pone.0009098","volume":"5","author":"L Gakhar","year":"2010","unstructured":"Gakhar L, Bartlett JA, Penterman J, Mizrachi D, Singh PK, Mallampalli RK, et al. PLUNC is a novel airway surfactant protein with anti-biofilm activity. PLoS One. 2010;5:e9098.","journal-title":"PLoS One"},{"key":"1454_CR16","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.ajpath.2013.01.050","volume":"182","author":"Y Liu","year":"2013","unstructured":"Liu Y, Bartlett JA, Di ME, Bomberger JM, Chan YR, Gakhar L, et al. SPLUNC1\/BPIFA1 contributes to pulmonary host defense against Klebsiella pneumoniae respiratory infection. Am J Pathol. 2013;182:1519\u201331.","journal-title":"Am J Pathol"},{"key":"1454_CR17","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.4049\/jimmunol.1202340","volume":"191","author":"Y Liu","year":"2013","unstructured":"Liu Y, Di ME, Chu HW, Liu X, Wang L, Wenzel S, et al. Increased susceptibility to pulmonary pseudomonas infection in Splunc1 knockout mice. J Immunol. 2013;191:4259\u201368.","journal-title":"J Immunol"},{"key":"1454_CR18","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1128\/IAI.00500-12","volume":"81","author":"S Sayeed","year":"2013","unstructured":"Sayeed S, Nistico L, St Croix C, Di YP. Multifunctional role of human SPLUNC1 in Pseudomonas aeruginosa infection. Infect Immun. 2013;81:285\u201391.","journal-title":"Infect Immun"},{"key":"1454_CR19","doi-asserted-by":"crossref","first-page":"15973","DOI":"10.1073\/pnas.1311999110","volume":"110","author":"AL Garland","year":"2013","unstructured":"Garland AL, Walton WG, Coakley RD, Tan CD, Gilmore RC, Hobbs CA, et al. Molecular basis for pH-dependent mucosal dehydration in cystic fibrosis airways. Proc Natl Acad Sci U S A. 2013;110:15973\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1454_CR20","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.1128\/AAC.00975-16","volume":"60","author":"S Ahmad","year":"2016","unstructured":"Ahmad S, Tyrrell J, Walton WG, Tripathy A, Redinbo MR, Tarran R. Short palate, lung, and nasal epithelial clone 1 has antimicrobial and Antibiofilm activities against the Burkholderia cepacia complex. Antimicrob Agents Chemother. 2016;60:6003\u201312.","journal-title":"Antimicrob Agents Chemother"},{"key":"1454_CR21","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1021\/acs.biochem.6b00271","volume":"55","author":"WG Walton","year":"2016","unstructured":"Walton WG, Ahmad S, Little MS, Kim CS, Tyrrell J, Lin Q, et al. Structural features essential to the antimicrobial functions of human SPLUNC1. Biochemistry. 2016;55:2979\u201391.","journal-title":"Biochemistry"},{"key":"1454_CR22","doi-asserted-by":"crossref","first-page":"e13224","DOI":"10.1371\/journal.pone.0013224","volume":"5","author":"G McGillivary","year":"2010","unstructured":"McGillivary G, Bakaletz LO. The multifunctional host defense peptide SPLUNC1 is critical for homeostasis of the mammalian upper airway. PLoS One. 2010;5:e13224.","journal-title":"PLoS One"},{"key":"1454_CR23","doi-asserted-by":"crossref","first-page":"11412","DOI":"10.1073\/pnas.0903609106","volume":"106","author":"A Garcia-Caballero","year":"2009","unstructured":"Garcia-Caballero A, Rasmussen JE, Gaillard E, Watson MJ, Olsen JC, Donaldson SH, et al. SPLUNC1 regulates airway surface liquid volume by protecting ENaC from proteolytic cleavage. Proc Natl Acad Sci U S A. 2009;106:11412\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1454_CR24","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1164\/rccm.201812-2303LE","volume":"200","author":"S Ahmad","year":"2019","unstructured":"Ahmad S, Gilmore RC, Alexis NE, Tarran R. SPLUNC1 loses its antimicrobial activity in acidic cystic fibrosis airway secretions. Am J Respir Crit Care Med. 2019;200:633\u20136.","journal-title":"Am J Respir Crit Care Med"},{"key":"1454_CR25","doi-asserted-by":"crossref","first-page":"e36313","DOI":"10.1371\/journal.pone.0036313","volume":"7","author":"L Delhaes","year":"2012","unstructured":"Delhaes L, Monchy S, Frealle E, Hubans C, Salleron J, Leroy S, et al. The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic management. PLoS One. 2012;7:e36313.","journal-title":"PLoS One"},{"key":"1454_CR26","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1096\/fj.201701126R","volume":"32","author":"CS Kim","year":"2018","unstructured":"Kim CS, Ahmad S, Wu T, Walton WG, Redinbo MR, Tarran R. SPLUNC1 is an allosteric modulator of the epithelial sodium channel. FASEB J. 2018;32:2478\u201391.","journal-title":"FASEB J"},{"key":"1454_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/13993003.00668-2018","volume":"52","author":"MJ Webster","year":"2018","unstructured":"Webster MJ, Reidel B, Tan CD, Ghosh A, Alexis NE, Donaldson SH, et al. SPLUNC1 degradation by the cystic fibrosis mucosal environment drives airway surface liquid dehydration. Eur Respir J. 2018;52:1.","journal-title":"Eur Respir J"},{"key":"1454_CR28","first-page":"L192","volume":"314","author":"ST Terryah","year":"2018","unstructured":"Terryah ST, Fellner RC, Ahmad S, Moore PJ, Reidel B, Sesma JI, et al. Evaluation of a SPLUNC1-derived peptide for the treatment of cystic fibrosis lung disease. Am J Phys Lung Cell Mol Phys. 2018;314:L192\u2013205.","journal-title":"Am J Phys Lung Cell Mol Phys"},{"key":"1454_CR29","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1574-6968.2002.tb11403.x","volume":"215","author":"CC Fehlner-Gardiner","year":"2002","unstructured":"Fehlner-Gardiner CC, Valvano MA. Cloning and characterization of the Burkholderia vietnamiensis norM gene encoding a multi-drug efflux protein. FEMS Microbiol Lett. 2002;215:279\u201383.","journal-title":"FEMS Microbiol Lett"},{"key":"1454_CR30","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1152\/physrev.00007.2002","volume":"82","author":"S Kellenberger","year":"2002","unstructured":"Kellenberger S, Schild L. Epithelial sodium channel\/degenerin family of ion channels: a variety of functions for a shared structure. Physiol Rev. 2002;82:735\u201367.","journal-title":"Physiol Rev"},{"key":"1454_CR31","doi-asserted-by":"crossref","first-page":"F833","DOI":"10.1152\/ajprenal.00088.2003","volume":"285","author":"OA Weisz","year":"2003","unstructured":"Weisz OA, Johnson JP. Noncoordinate regulation of ENaC: paradigm lost? Am J Physiol Ren Physiol. 2003;285:F833\u201342.","journal-title":"Am J Physiol Ren Physiol"},{"key":"1454_CR32","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ijporl.2014.01.014","volume":"78","author":"K Irander","year":"2014","unstructured":"Irander K, Borres MP, Ghafouri B. The effects of physical exercise and smoking habits on the expression of SPLUNC1 in nasal lavage fluids from allergic rhinitis subjects. Int J Pediatr Otorhinolaryngol. 2014;78:618\u201322.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"1454_CR33","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1126\/science.284.5418.1313","volume":"284","author":"JA Hoffmann","year":"1999","unstructured":"Hoffmann JA, Kafatos FC, Janeway CA, Ezekowitz RA. Phylogenetic perspectives in innate immunity. Science. 1999;284:1313\u20138.","journal-title":"Science"},{"key":"1454_CR34","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10059-010-0146-4","volume":"30","author":"JH Ryu","year":"2010","unstructured":"Ryu JH, Kim CH, Yoon JH. Innate immune responses of the airway epithelium. Mol Cell. 2010;30:173\u201383.","journal-title":"Mol Cell"},{"key":"1454_CR35","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1128\/JCM.42.3.1024-1029.2004","volume":"42","author":"S Joly","year":"2004","unstructured":"Joly S, Maze C, McCray PB Jr, Guthmiller JM. Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. J Clin Microbiol. 2004;42:1024\u20139.","journal-title":"J Clin Microbiol"},{"key":"1454_CR36","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4049\/jimmunol.1001769","volume":"187","author":"L Lukinskiene","year":"2011","unstructured":"Lukinskiene L, Liu Y, Reynolds SD, Steele C, Stripp BR, Leikauf GD, et al. Antimicrobial activity of PLUNC protects against Pseudomonas aeruginosa infection. J Immunol. 2011;187:382\u201390.","journal-title":"J Immunol"},{"key":"1454_CR37","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.4049\/jimmunol.179.6.3995","volume":"179","author":"HW Chu","year":"2007","unstructured":"Chu HW, Thaikoottathil J, Rino JG, Zhang G, Wu Q, Moss T, et al. Function and regulation of SPLUNC1 protein in mycoplasma infection and allergic inflammation. J Immunol. 2007;179:3995\u20134002.","journal-title":"J Immunol"},{"key":"1454_CR38","first-page":"L990","volume":"305","author":"CA Hobbs","year":"2013","unstructured":"Hobbs CA, Blanchard MG, Alijevic O, Tan CD, Kellenberger S, Bencharit S, et al. Identification of the SPLUNC1 ENaC-inhibitory domain yields novel strategies to treat sodium hyperabsorption in cystic fibrosis airway epithelial cultures. Am J Phys Lung Cell Mol Phys. 2013;305:L990\u2013L1001.","journal-title":"Am J Phys Lung Cell Mol Phys"},{"key":"1454_CR39","doi-asserted-by":"crossref","first-page":"14118","DOI":"10.1038\/ncomms14118","volume":"8","author":"T Wu","year":"2017","unstructured":"Wu T, Huang J, Moore PJ, Little MS, Walton WG, Fellner RC, et al. Identification of BPIFA1\/SPLUNC1 as an epithelium-derived smooth muscle relaxing factor. Nat Commun. 2017;8:14118.","journal-title":"Nat Commun"},{"key":"1454_CR40","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1099\/0022-1317-49-10-875","volume":"49","author":"U Sajjan","year":"2000","unstructured":"Sajjan U, Wu Y, Kent G, Forstner J. Preferential adherence of cable-piliated burkholderia cepacia to respiratory epithelia of CF knockout mice and human cystic fibrosis lung explants. J Med Microbiol. 2000;49:875\u201385.","journal-title":"J Med Microbiol"},{"key":"1454_CR41","doi-asserted-by":"crossref","first-page":"4547","DOI":"10.1128\/IAI.70.8.4547-4555.2002","volume":"70","author":"U Schwab","year":"2002","unstructured":"Schwab U, Leigh M, Ribeiro C, Yankaskas J, Burns K, Gilligan P, et al. Patterns of epithelial cell invasion by different species of the Burkholderia cepacia complex in well-differentiated human airway epithelia. Infect Immun. 2002;70:4547\u201355.","journal-title":"Infect Immun"},{"key":"1454_CR42","doi-asserted-by":"crossref","first-page":"6607","DOI":"10.1128\/IAI.71.11.6607-6609.2003","volume":"71","author":"UE Schwab","year":"2003","unstructured":"Schwab UE, Ribeiro CM, Neubauer H, Boucher RC. Role of actin filament network in Burkholderia multivorans invasion in well-differentiated human airway epithelia. Infect Immun. 2003;71:6607\u20139.","journal-title":"Infect Immun"},{"key":"1454_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/jmm.0.47788-0","volume":"58","author":"S McClean","year":"2009","unstructured":"McClean S, Callaghan M. Burkholderia cepacia complex: epithelial cell-pathogen confrontations and potential for therapeutic intervention. J Med Microbiol. 2009;58:1\u201312.","journal-title":"J Med Microbiol"},{"issue":"Pt 8","key":"1454_CR44","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1099\/00221287-144-8-2179","volume":"144","author":"A Carlsson","year":"1998","unstructured":"Carlsson A, Nystrom T, de Cock H, Bennich H. Attacin--an insect immune protein--binds LPS and triggers the specific inhibition of bacterial outer-membrane protein synthesis. Microbiology. 1998;144(Pt 8):2179\u201388.","journal-title":"Microbiology"},{"key":"1454_CR45","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1172\/JCI16889","volume":"111","author":"H Wu","year":"2003","unstructured":"Wu H, Kuzmenko A, Wan S, Schaffer L, Weiss A, Fisher JH, et al. Surfactant proteins a and D inhibit the growth of gram-negative bacteria by increasing membrane permeability. J Clin Invest. 2003;111:1589\u2013602.","journal-title":"J Clin Invest"},{"key":"1454_CR46","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fmicb.2011.00021","volume":"2","author":"CB Stone","year":"2011","unstructured":"Stone CB, Bulir DC, Emdin CA, Pirie RM, Porfilio EA, Slootstra JW, et al. Chlamydia pneumoniae CdsL regulates CdsN ATPase activity, and disruption with a peptide mimetic prevents bacterial invasion. Front Microbiol. 2011;2:21.","journal-title":"Front Microbiol"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-020-01454-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-020-01454-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-020-01454-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T19:54:42Z","timestamp":1626465282000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-020-01454-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,17]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1454"],"URL":"https:\/\/doi.org\/10.1186\/s12931-020-01454-5","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,17]]},"assertion":[{"value":"20 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Robert Tarran holds equity in Eldec Pharmaceuticals. The other authors declare no competing financial interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"190"}}